0001493152-22-017831.txt : 20220627 0001493152-22-017831.hdr.sgml : 20220627 20220627161015 ACCESSION NUMBER: 0001493152-22-017831 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220623 FILED AS OF DATE: 20220627 DATE AS OF CHANGE: 20220627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Telling Fred CENTRAL INDEX KEY: 0001382225 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 221044636 MAIL ADDRESS: STREET 1: 501 ELLIOTT AVE. W. STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 4/A 1 ownership.xml X0306 4/A 2022-06-23 2022-06-24 0 0001174940 ORAGENICS INC OGEN 0001382225 Telling Fred 4902 EISENHOWER BOULEVARD TAMPA FL 33634 1 0 0 0 Non-Employee Director Option (Right to Buy) 0.2950 2022-06-23 4 A 0 250000 0 A 2022-06-23 2032-06-23 Common Stock 250000 250000 D Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022. Due to a clerical error, the Form 4, as originally filed, incorrectly reported the option expiration date. The Form 4, as amended by this Form 4/A, correctly reports such information. No other changes have been made to the originally filed Form 4. /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling 2022-06-27